Actively Recruiting

Age: 18Years - 75Years
All Genders
NCT05577143

Blood Screening for Adult Colorectal Cancer

Led by University Hospital, Lille · Updated on 2025-12-26

303

Participants Needed

1

Research Sites

153 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Lille

Lead Sponsor

M

Ministry of Health, France

Collaborating Sponsor

AI-Summary

What this Trial Is About

Multicenter, inter-regional, case-control study with the primary objective of evaluating the discriminative power of the blood biomarker TFPI-1 to separate patients with histologically proven CRC from an asymptomatic control population between 50 and 75 years of age with normal colonoscopy.

CONDITIONS

Official Title

Blood Screening for Adult Colorectal Cancer

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients suspected of colorectal cancer who require colonoscopy
  • Patients between 50 and 75 years old who are asymptomatic and need follow-up colonoscopy
  • If colonoscopy is normal post-inclusion, patient will be assigned to control group
  • If colonoscopy shows mucosal lesions, patient will be assigned to colorectal cancer or polyps group based on pathology
Not Eligible

You will not qualify if you...

  • Clinical conditions that may raise TFPI-1 or TFPI-2 levels: acute coronary syndrome, severe sepsis, decompensated cirrhosis, pregnancy, chronic inflammatory bowel disease, colitis, or radiation rectitis
  • Endoscopic polypectomy without prior histological confirmation
  • Emergency conditions such as occlusion or peritonitis
  • Minors
  • Persons under legal protection or unable to consent
  • Persons not affiliated with a social security system
  • Pregnant women, women in labor, or nursing mothers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hôpital HURIEZ - Chirurgie digestive et transplantation

Lille, France

Actively Recruiting

Loading map...

Research Team

P

Philippe ZERBIB, MD,PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here